180 Life Sciences Corp (ATNF)
2.24
-0.04
(-1.75%)
USD |
NASDAQ |
Nov 22, 16:00
2.36
+0.12
(+5.36%)
After-Hours: 20:00
180 Life Sciences Total Liabilities (Quarterly): 6.736M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 6.736M |
| June 30, 2024 | 4.329M |
| March 31, 2024 | 4.396M |
| December 31, 2023 | 5.387M |
| September 30, 2023 | 5.107M |
| June 30, 2023 | 6.951M |
| March 31, 2023 | 7.782M |
| December 31, 2022 | 8.306M |
| September 30, 2022 | 8.261M |
| Date | Value |
|---|---|
| June 30, 2022 | 10.57M |
| March 31, 2022 | 18.77M |
| December 31, 2021 | 23.39M |
| September 30, 2021 | 27.93M |
| June 30, 2021 | 53.55M |
| March 31, 2021 | 37.40M |
| December 31, 2020 | 25.25M |
| December 31, 2019 | 13.31M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.329M
Minimum
Jun 2024
53.55M
Maximum
Jun 2021
15.73M
Average
8.306M
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
| Seelos Therapeutics Inc | 30.51M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
| Theriva Biologics Inc | 15.47M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.47M |
| Shareholders Equity (Quarterly) | 3.734M |